Karin Eastham Nektar Therapeutics (NKTR) insider trading activity
Karin Eastham is Director of NEKTAR THERAPEUTICS. Currently has a direct ownership of 23,233 shares of NKTR, which is worth approximately $28,576. The most recent transaction as insider was on Sep 16, 2022, when has been sold 10,200 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
23.2K
0%
3M change
0%
12M change
Total Value Held
$28,576
KARIN EASTHAM Transaction History
Also insider at
KE
Karin Eastham
Director
San Francisco, CA